Cargando…
ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases and is characterized by high chemoresistance, leading to the lack of effective therapeutic approaches and grim prognosis. Despite increasing understanding of the mechanisms of chemoresistance in cancer and the role of ATP...
Autores principales: | Adamska, Aleksandra, Falasca, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079284/ https://www.ncbi.nlm.nih.gov/pubmed/30090003 http://dx.doi.org/10.3748/wjg.v24.i29.3222 |
Ejemplares similares
-
ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics
por: López-Fernández, Luis A.
Publicado: (2018) -
Human ATP-binding cassette (ABC) transporter family
por: Vasiliou, Vasilis, et al.
Publicado: (2009) -
The impact of ATP-binding cassette transporters on metabolic diseases
por: Ye, Zixiang, et al.
Publicado: (2020) -
The ABCC6 transporter: what lessons can be learnt from other ATP-binding cassette transporters?
por: Vanakker, Olivier M., et al.
Publicado: (2013) -
ATP-binding cassette (ABC) transporters in normal and pathological lung
por: van der Deen, Margaretha, et al.
Publicado: (2005)